Abstract

Objective The aim of this study was to evaluate the relationship between the oxidant-antioxidant status, endothelial dysfunction, lipid metabolism, and metabolic syndrome risk in women with polycystic ovary syndrome (PCOS). Materials and Methods Forty-five obese (BMI >30 kg/m2) woman diagnosed with PCOS in the study, forty-five nonobese (BMI <30 kg/m2) PCOS diagnosis working groups, and forty-nine healthy control groups were created with patients. Serum malondialdehyde (MDA) levels with antioxidant activities, such as SOD, GSH, GPx, and CAT activities, were measured by spectrophotometry. Results There was a statistically significant difference in the mean serum MDA level in the obese PCOS group compared to the nonobese group and the control group (p < 0.001). When the antioxidant parameters, such as SOD, GPx, GSH, and CAT, were compared with the healthy control group, nonobese, and obese PCOS groups, the difference between the groups was statistically significant (p < 0.001). A positive correlation was observed between MDA and BMI, triglyceride, LDL, SBP, DBP, and HOMA-IR in the PCOS patient group. Conclusion Oxidative stress and decreased antioxidant parameters in PCOS patients were correlated with hyperinsulinemia, hypertension, and dyslipidemia findings, and we think that this oxidative stress condition may contribute to metabolic syndrome and cardiovascular diseases in PCOS patients.

Highlights

  • Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 6% to 20% of women at reproductive age [1]

  • No statistically different results were observed between all three groups with respect to age (p > 0.001). ere was a statistically significant difference between the study groups in the waist-hip ratio, weight(kg), height, Body mass index (BMI), menstrual cycle, Ferriman–Gallwey score, systolic blood pressure (SBP), and diastolic blood pressure (DBP) parameters (p < 0.001)

  • Androstenedione, total testosterone, DHEA-S, luteinizing hormone (LH) levels, insulin, SHBG, HDL, LDL, triglyceride, total cholesterol, and FPG levels were significantly different in the obese polycystic ovary syndrome (PCOS) group compared to the nonobese PCOS and control group (p < 0.001) (Table 2)

Read more

Summary

Introduction

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 6% to 20% of women at reproductive age [1]. Women with PCOS have hyperandrogenism and hirsutism, oligo or amenorrhea, and anovulation. There is a long history of study on PCOS, its etiology is still unknown. The role of inflammatory mechanisms, endothelial damage, oxidative stress, and genetic mechanisms are explained [2, 3]. It has been reported that women with polycystic ovary syndrome have abnormalities in estrogen and androgen metabolism. It has been determined that PCOS may be caused by abnormal function of the hypothalamic-pituitary-ovarian (HPO axis). LH has been found to induce androgen biosynthesis by the theca interna cells. FSH has been found to stimulate aromatase activity by the granulosa cells

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call